EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor-and PSMA-targeting ligands
K Sjögreen Gleisner, N Chouin, PM Gabina… - European journal of …, 2022 - Springer
The purpose of the EANM Dosimetry Committee is to provide recommendations and
guidance to scientists and clinicians on patient-specific dosimetry. Radiopharmaceuticals …
guidance to scientists and clinicians on patient-specific dosimetry. Radiopharmaceuticals …
Peptide receptor radionuclide therapy: looking back, looking forward
D Feijtel, M de Jong… - Current Topics in Medicinal …, 2020 - ingentaconnect.com
Peptide receptor radionuclide therapy (PRRT) is a highly effective anti-cancer treatment
modality for patients with non-resectable, metastasized neuroendocrine tumors (NETs) …
modality for patients with non-resectable, metastasized neuroendocrine tumors (NETs) …
Radiological contrast agents and radiopharmaceuticals
MS D'Souza, R Miguel, SD Ray - Side Effects of Drugs Annual, 2020 - Elsevier
Abstract Side Effects of Drugs Annual is an annual publication that publishes side effects,
adverse reactions and toxicities associated with medications. The series supplements the …
adverse reactions and toxicities associated with medications. The series supplements the …